Used in pharmaceutical research as a key intermediate in the synthesis of immunomodulatory drugs, particularly those targeting protein degradation pathways such as cereblon E3 ligase modulators. It plays a role in the development of compounds with potential anticancer and anti-inflammatory activity. Its structure supports targeted protein degradation, making it valuable in the design of PROTACs (proteolysis-targeting chimeras) and other therapeutic agents aimed at difficult-to-treat diseases.